91 related articles for article (PubMed ID: 26436510)
1. Significance of Ebp1 and p53 protein expression in cervical cancer.
Liu L; Li XD; Chen HY; Cui JS; Xu DY
Genet Mol Res; 2015 Oct; 14(4):11860-6. PubMed ID: 26436510
[TBL] [Abstract][Full Text] [Related]
2. Ebp1 protein expression in cervical cancer tissue and its significance.
Liu L; Xu DY; Yang SS; Li XD
Genet Mol Res; 2015 May; 14(2):5496-500. PubMed ID: 26125746
[TBL] [Abstract][Full Text] [Related]
3. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
He HC; Ling XH; Zhu JG; Fu X; Han ZD; Liang YX; Deng YH; Lin ZY; Chen G; Chen YF; Mo RJ; Zhong WD
Mol Biol Rep; 2013 May; 40(5):3799-805. PubMed ID: 23283744
[TBL] [Abstract][Full Text] [Related]
5. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
7. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
8. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
9. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C
Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333
[TBL] [Abstract][Full Text] [Related]
10. EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression.
Liu H; Li Z; Li L; Peng H; Zhang Z
Tumour Biol; 2015 Nov; 36(11):8325-31. PubMed ID: 26008146
[TBL] [Abstract][Full Text] [Related]
11. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
12. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis.
Su HC; Wu SC; Yen LC; Chiao LK; Wang JK; Chiu YL; Ho CL; Huang SM
Sci Rep; 2020 Jul; 10(1):11837. PubMed ID: 32678267
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 product in patients with stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Breitenecker G
Anticancer Res; 1992; 12(6B):2241-2. PubMed ID: 1295470
[TBL] [Abstract][Full Text] [Related]
16. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
[TBL] [Abstract][Full Text] [Related]
17. Deregulated LAP2α expression in cervical cancer associates with aberrant E2F and p53 activities.
Ward MC; van der Watt PJ; Tzoneva G; Leaner VD
IUBMB Life; 2011 Nov; 63(11):1018-26. PubMed ID: 21990273
[TBL] [Abstract][Full Text] [Related]
18. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
20. Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.
Yu Y; Chen W; Zhang Y; Hamburger AW; Pan H; Zhang Z
Int J Cancer; 2007 May; 120(9):1909-13. PubMed ID: 17266032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
